Randy Spahr
Corporate Officer/Principal chez THE ANDERSONS, INC.
Profil
Andy Spahr has held multiple positions throughout his career.
Currently, he is the Director at PhosphoSolutions LLC since 2019, the Director at Maumee Ventures LLC since 2017, and the Vice President at The Andersons, Inc. since 2021.
In terms of education, Mr. Spahr completed his undergraduate degree at Miami University and obtained an MBA from Stephen M.
Ross School of Business.
Postes actifs de Randy Spahr
Sociétés | Poste | Début |
---|---|---|
THE ANDERSONS, INC. | Corporate Officer/Principal | 01/01/2021 |
Maumee Ventures LLC
Maumee Ventures LLC Investment ManagersFinance Maumee Ventures LLC (Maumee Ventures) is a venture capital subsidiary of The Andersons, Inc founded in 2015. The firm is headquartered in Maumee, Ohio. | Directeur/Membre du Conseil | 01/03/2017 |
PhosphoSolutions LLC
PhosphoSolutions LLC BiotechnologyHealth Technology PhosphoSolutions LLC manufacturer of phospho-proteomic solutions, offering a range of pan and phospho-specific antibodies. Its products include GABA receptors, signal transduction, visual systems and catecholamine signaling products. The company was founded by by Michael D. Browning, John W. Haycock, and Andrew J. Czernik in 2001 and is headquartered in Aurora, CO. | Directeur/Membre du Conseil | 01/04/2019 |
Formation de Randy Spahr
Miami University | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
THE ANDERSONS, INC. | Commercial Services |
Entreprise privées | 2 |
---|---|
Maumee Ventures LLC
Maumee Ventures LLC Investment ManagersFinance Maumee Ventures LLC (Maumee Ventures) is a venture capital subsidiary of The Andersons, Inc founded in 2015. The firm is headquartered in Maumee, Ohio. | Finance |
PhosphoSolutions LLC
PhosphoSolutions LLC BiotechnologyHealth Technology PhosphoSolutions LLC manufacturer of phospho-proteomic solutions, offering a range of pan and phospho-specific antibodies. Its products include GABA receptors, signal transduction, visual systems and catecholamine signaling products. The company was founded by by Michael D. Browning, John W. Haycock, and Andrew J. Czernik in 2001 and is headquartered in Aurora, CO. | Health Technology |